Reimagining drug discovery and development through the lens of technology

Our Approach

AI-enabled precision medicine

Our partnership model with biopharma focuses on developing biomarker-driven strategies using our AI intelligence platform uncovering opportunities that were undetectable with conventional approaches. We license or co-develop clinical-stage therapeutics to ensure these highly efficacious drugs reach patients that need them most.

Learn More

Vanguard in therapeutics

Pathos was borne out of the idea that AI can transform each step of the drug development process, from patient selection, biomarker development, trial design, and clinical trial operations to bring precision medicines to market at an unimaginable pace.

Learn More